Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-24-010452
Filing Date
2024-04-02
Accepted
2024-04-01 18:08:28
Documents
5
Effectiveness Date
2024-04-02

Document Format Files

Seq Description Document Type Size
1 FORM S-8 zvra20240315_s8.htm S-8 50392
2 EXHIBIT 5.1 ex_640266.htm EX-5.1 11918
3 EXHIBIT 23.1 ex_640267.htm EX-23.1 2740
4 EXHIBIT FILING FEES ex_640269.htm EX-FILING FEES 12589
5 lw.jpg GRAPHIC 11017
  Complete submission text file 0001437749-24-010452.txt   94053
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278445 | Film No.: 24811472
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)